Loomis, Sayles & Company’s Trueblue TBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
– Sell
-282
Closed -$8K – 920
2017
Q4
$8K Hold
282
– – ﹤0.01% 803
2017
Q3
$6K Hold
282
– – ﹤0.01% 834
2017
Q2
$7K Hold
282
– – ﹤0.01% 840
2017
Q1
$8K Hold
282
– – ﹤0.01% 829
2016
Q4
$7K Hold
282
– – ﹤0.01% 877
2016
Q3
$6K Buy
+282
New +$6.16K ﹤0.01% 857
2016
Q2
– Sell
-327
Closed -$9K – 1119
2016
Q1
$9K Buy
327
+245
+299% +$5.67K ﹤0.01% 846
2015
Q4
$2K Hold
82
– – ﹤0.01% 998
2015
Q3
$2K Buy
+82
New +$2.1K ﹤0.01% 989

Other funds holding TBI

Loomis, Sayles & Company's TBI Position: Q1 2018 in Review

Loomis, Sayles & Company sold out of Trueblue (TBI) in Q1 2018, closing a stake of 282 shares — an estimated $8K sold.

Loomis, Sayles & Company first reported a position in TBI in Q3 2015 and held it in 9 quarters. The position peaked at $9K in Q1 2016. 196 funds tracked by Wall St. Rank hold TBI as of Q1 2018.

  • Loomis, Sayles & Company reported no remaining Trueblue position as of Q1 2018 after selling out during the quarter.
  • Loomis, Sayles & Company sold 282 Trueblue shares in Q1 2018, an estimated $8K.
  • Loomis, Sayles & Company first reported a position in Trueblue in Q3 2015 and held it in 9 quarters.
  • Loomis, Sayles & Company's Trueblue position peaked at $9K in Q1 2016.
  • 196 funds tracked by Wall St. Rank held Trueblue as of Q1 2018.

Based on Loomis, Sayles & Company's 13F filing for Q1 2018, filed 11 May 2018.